Oracle Launches Integrated Mass-serialization, Pedigree Application For Pharma Industry

Oracle claimed that the new solution helps pharmaceutical manufacturers facilitate compliance with emerging electronic pedigree (ePedigree) initiatives and regulatory requirements, reduce business and reputational risk associated with the rising incidence of drug counterfeiting and product diversion while extending value across the pharmaceutical supply chain.

Additionally, Oracle’s new solution generates, stores, transmits and authenticates drug product serial data and ePedigree data as pharmaceutical products move across the supply chain. This facilitates counterfeit threat identification and streamlines compliance.

Oracle said that the integrated analytics within the solution provide pharmaceutical manufacturers with expanded insight into possible threats.

The solution can be used by pharmaceutical companies to improve the efficiency and accuracy of returns management and reduce associated losses.

Further, this software helps pharmaceutical companies maintain channel integrity by enabling them to reduce product diversions, such as from lower reimbursement locations to higher reimbursement locations. It also can help reduce revenue leakage by helping to improve scrutiny of chargeback rebates paid out to wholesalers.

Oracle Pedigree and Serialisation Manager is built on an open standards-based Service-Oriented Architecture (SOA) and Oracle Fusion Middleware applications to integrate seamlessly with existing Oracle and third-party systems for manufacturing, packaging and shipping and receiving.